Pacific Shuanglin Bio-pharmacy Co., Ltd.

Chinese maker of plasma-derived blood products and immunoglobulins

What Pacific Shuanglin Bio-pharmacy does

Pacific Shuanglin Bio-pharmacy collects human blood plasma and processes it into medicines used in hospitals, such as albumin for burn and trauma patients, immunoglobulins that supply protective antibodies, and clotting proteins for people who bleed too easily. It researches, manufactures, and sells these products in China and abroad. The company also runs plasma collection operations and offers related consulting, trading, and technology services.

How Pacific Shuanglin Bio-pharmacy makes money

It earns revenue by selling plasma-derived therapies—albumin, immunoglobulins, and coagulation products—to hospitals and distributors in China and overseas markets. Its own blood and plasma collection operations secure the raw material that supply, and therefore output and sales, depend on.

Products & services

• Human serum albumin
• Human immunoglobulin (pH4) and lyophilized intravenous immunoglobulin (pH4)
• Hepatitis B human immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin
• Human coagulation factor VIII
• Human fibrinogen and human prothrombin complex concentrate
• Intravenous cytomegalovirus and respiratory syncytial virus immunoglobulins